Targeting fatty acid metabolism in glioblastoma

J Miska, NS Chandel - The Journal of Clinical Investigation, 2023 - Am Soc Clin Investig
Glioblastoma (GBM) is a primary tumor of the brain defined by its uniform lethality and
resistance to conventional therapies. There have been considerable efforts to untangle the …

The use of ketogenic diets in cancer patients: a systematic review

M Römer, J Dörfler, J Huebner - Clinical and experimental medicine, 2021 - Springer
Ketogenic diets are a widely known, yet controversial treatment for cancer patients. In this
review, we summarize the clinical evidence for anti-tumor effects, as well as the effects on …

Systems level profiling of chemotherapy-induced stress resolution in cancer cells reveals druggable trade-offs

P Saavedra-García, M Roman-Trufero… - Proceedings of the …, 2021 - National Acad Sciences
Cancer cells can survive chemotherapy-induced stress, but how they recover from it is not
known. Using a temporal multiomics approach, we delineate the global mechanisms of …

Integrative rare disease biomedical profile based network supporting drug repurposing or repositioning, a case study of glioblastoma

E McGowan, J Sanjak, EA Mathé, Q Zhu - Orphanet Journal of Rare …, 2023 - Springer
Background Glioblastoma (GBM) is the most aggressive and common malignant primary
brain tumor; however, treatment remains a significant challenge. This study aims to identify …

Cellular redox imbalance on the crossroad between mitochondrial dysfunction, senescence, and proliferation

R Bakalova, I Aoki, Z Zhelev, T Higashi - Redox Biology, 2022 - Elsevier
Recent studies demonstrate that redox imbalance of NAD+/NADH and NADP+/NADPH pairs
due to impaired respiration may trigger two “hidden” metabolic pathways on the crossroad …

The efficacy of an unrestricted cycling ketogenic diet in preclinical models of IDH wild-type and IDH mutant glioma

R Javier, W Wang, M Drumm, K McCortney… - PloS one, 2022 - journals.plos.org
Infiltrative gliomas are the most common neoplasms arising in the brain, and remain largely
incurable despite decades of research. A subset of these gliomas contains mutations in …

[HTML][HTML] Integrative Rare Disease Biomedical Profile based Network Supporting Drug Repurposing, a case study of Glioblastoma

E McGowan, J Sanjak, EA Mathé, Q Zhu - Research Square, 2023 - ncbi.nlm.nih.gov
Background Glioblastoma (GBM) is the most aggressive and common malignant primary
brain tumor; however, treatment remains a significant challenge. This study aims to identify …

[HTML][HTML] Targeting super-enhancers reprograms glioblastoma central carbon metabolism

TTT Nguyen, MA Westhoff, G Karpel-Massler… - Oncotarget, 2021 - ncbi.nlm.nih.gov
The concept that tumor cells demand a distinct form of metabolism was appreciated almost a
century ago when the German biochemist Otto Warburg realized that tumor cells heavily …

[图书][B] Epigenome and the lipidome rewiring for targeting IDH-mutant-gliomas

L Elahi - 2023 - search.proquest.com
Missense mutation in the gene isocitrate dehydrogenase (IDH) rewires the metabolic and
chromatin landscape of IDH mutant (MT) gliomas making them distinct from IDH wildtype …

The efficacy of a ketogenic diet in preclinical models of IDH wild-type and IDH mutant glioma

R Javier, W Wang, M Drumm, K McCortney… - bioRxiv, 2021 - biorxiv.org
Infiltrative gliomas are the most common neoplasms arising in the brain, and remain largely
incurable despite decades of research. A subset of these gliomas contains mutations in …